Escrow Agreements in the Biotechnology Industry
88 Contracts & Agreements
- CATALYST BIOSCIENCES, INC. (1 contract)
- Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (MARIZYME INC, Filed With SEC on November 2, 2022)
- Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (MARIZYME INC, Filed With SEC on May 16, 2022)
- Agreement to Transfer Option and Amendatory Agreement, dated March 3, 2022, between Marizyme, Inc., James Sapirstein and Bevilacqua PLLC, as escrow agent (MARIZYME INC, Filed With SEC on March 31, 2022)
- Escrow Agreement dated December 21, 2021 between Petra Acquisition , Inc., Continental Stock Transfer & Trust Company, Meteora Special Opportunity Fund I, LP and Meteora Capital... (Petra Acquisition Inc., Filed With SEC on December 23, 2021)
- Escrow Agreement dated November 6, 2020 by and between the registrant, Continental Stock Transfer & Trust Company, and Lawrence Pemble (KBL MERGER CORP. IV, Filed With SEC on November 12, 2020)
- Escrow Agreement, dated October 7, 2020, by and among the Company, Continental Stock Transfer & Trust Company and the Companys Initial Stockholders (Petra Acquisition Inc., Filed With SEC on October 13, 2020)
- Form of Stock Escrow Agreement (Petra Acquisition Inc., Filed With SEC on September 21, 2020)
- Form of Escrow Agreement between the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (BCTG Acquisition Corp., Filed With SEC on August 31, 2020)
- Form of Stock Escrow Agreement (Petra Acquisition Inc., Filed With SEC on August 26, 2020)
- Form of Stock Escrow Agreement (Petra Acquisition Inc., Filed With SEC on August 19, 2020)
- Form of Stock Escrow Agreement (Petra Acquisition Inc., Filed With SEC on August 11, 2020)
- Stock Escrow Agreement, dated April 23, 2020, among the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (Chardan Healthcare Acquisition 2 Corp., Filed With SEC on April 29, 2020)
- Form of Escrow Agreement between the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (Chardan Healthcare Acquisition 2 Corp., Filed With SEC on April 16, 2020)
- Stock Escrow Agreement, dated March 5, 2020, among the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (LifeSci Acquisition Corp., Filed With SEC on March 11, 2020)
- Form of Escrow Agreement between the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (LifeSci Acquisition Corp., Filed With SEC on February 28, 2020)
- Escrow Agreement dated October 28, 2019, among Chardan Healthcare Acquisition Corp., Shareholder Representative Services LLC and Continental Stock Transfer & Trust Company (Chardan Healthcare Acquisition Corp., Filed With SEC on November 1, 2019)
- Form of Escrow Agreement (Chanticleer Holdings, Inc., Filed With SEC on May 28, 2019)
- Stock Escrow Agreement, dated May 9, 2019, among the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (Health Sciences Acquisitions Corp, Filed With SEC on May 15, 2019)
- Escrow Agreement dated May 13, 2019 (Bison Capital Acquisition Corp., Filed With SEC on May 15, 2019)
- Form of Stock Escrow Agreement among the Registrant, Continental Stock Transfer & Trust Company, and the Initial Stockholders (Health Sciences Acquisitions Corp, Filed With SEC on April 29, 2019)
- Stock Escrow Agreement, dated December 13, 2018, among the Registrant, Continental Stock Transfer & Trust Company and the initial stockholders (Chardan Healthcare Acquisition Corp., Filed With SEC on December 19, 2018)
- Form of Escrow Agreement between the Registrant, Continental Stock Transfer & Trust Company and the Initial Stockholders (Chardan Healthcare Acquisition Corp., Filed With SEC on December 4, 2018)
- Escrow Agreement, dated September 24, 2018 (OncBioMune Pharmaceuticals, Inc, Filed With SEC on November 14, 2018)
- Form of Escrow Agreement to be entered into by and among Bison Capital Acquisition Corp., Yinglin Mark Xu and Continental Stock Transfer & Trust Company (Bison Capital Acquisition Corp., Filed With SEC on September 13, 2018)
- Escrow Agreement for the offering by and between the Registrant, MDB Capital Group, LLC and Continental Stock Transfer & Trust Company dated November 24, 2017 (Cue Biopharma, Inc., Filed With SEC on December 5, 2017)
- Form of Amended and Restated Escrow Deposit Agreement by and among the Registrant, Signature Bank and the Underwriter (Genprex, Inc., Filed With SEC on September 22, 2017)
- Form of Escrow Deposit Agreement by and among the Registrant, Signature Bank and the Underwriter (Genprex, Inc., Filed With SEC on September 8, 2017)
- Form of Share Escrow Agreement (Inspyr Therapeutics, Inc., Filed With SEC on August 3, 2017)
- Escrow Agreement, dated June 19, 2017, among the Company, initial shareholders and Continental Stock Transfer & Trust Company (Bison Capital Acquisition Corp., Filed With SEC on June 26, 2017)
- Form of Escrow Agreement between the Registrant, Continental Stock Transfer & Trust Company and the Initial Shareholders (Bison Capital Acquisition Corp., Filed With SEC on May 31, 2017)
- ESCROW AGREEMENT (CURIS INC, Filed With SEC on May 4, 2017)
- FIRST AMENDMENT TO AGREEMENT OF PURCHASE AND SALE AND JOINT ESCROW INSTRUCTIONS (MANNKIND CORP, Filed With SEC on March 16, 2017)
- ESCROW DEPOSIT AGREEMENT (Moleculin Biotech, Inc., Filed With SEC on April 15, 2016)
- Form of Escrow Agreement (BIOTIME INC, Filed With SEC on September 25, 2015)
- ESCROW AGREEMENT (CATALYST BIOSCIENCES, INC., Filed With SEC on September 4, 2015)
- AMENDMENTNO. 1 TO ESCROW AGREEMENT (DelMar Pharmaceuticals, Inc., Filed With SEC on June 30, 2015)
- ESCROW AGREEMENT (XBiotech Inc., Filed With SEC on March 27, 2015)
- ESCROW AGREEMENT (XBiotech Inc., Filed With SEC on March 10, 2015)
- Escrow Agreement dated February 27, 2015 with the shareholders of MasTHerCell SA and Cell Therapy Holding SA and bondholders of MaSTherCell SA and Securities Transfer Corporation (Orgenesis Inc., Filed With SEC on March 5, 2015)
- ESCROW AGREEMENT (Chanticleer Holdings, Inc., Filed With SEC on February 17, 2015)
